AARD Competitors & Alternatives
Compare Aardvark Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
AARD
Main Stock$6.32
Tradestie Score
53
Market Cap
$319.10M
Analyst Upside
+129.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.23
|
$202.58M | - | 51 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$16.30
|
$199.71M | - | 50 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$54.78
|
$180.53M | - | 57 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.44
|
$170.45M | - | 51 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.10
|
$158.43M | - | 48 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.31
|
$154.27M | - | 54 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.84
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.43
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$26.78
|
$110.20M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.18
|
$71.69M | - | 46 | Compare |
More AARD Analysis
Data updated: Jul 26, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry